DrugPatentWatch Database Preview
Lannett Company Profile
Email this page to a colleague
What is the competitive landscape for LANNETT, and what generic and branded alternatives to LANNETT drugs are available?
LANNETT has two hundred and seven approved drugs.
There is one tentative approval on LANNETT drugs.
Summary for Lannett
| US Patents: | 0 |
| Tradenames: | 148 |
| Ingredients: | 138 |
| NDAs: | 207 |
| Patent Litigation for Lannett: | See patent lawsuits for Lannett |
| PTAB Cases with Lannett as petitioner: | See PTAB cases with Lannett as petitioner |
Drugs and US Patents for Lannett
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | INJECTABLE;INJECTION | 090883-001 | Aug 5, 2010 | DISCN | No | No | ⤷ Try it Free | ⤷ Try it Free | |||||
| Lannett Co Inc | MONOKET | isosorbide mononitrate | TABLET;ORAL | 020215-002 | Jun 30, 1993 | AB | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Lannett | LANIAZID | isoniazid | TABLET;ORAL | 080140-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try it Free | ⤷ Try it Free | |||||
| Lannett Co Inc | MORPHINE SULFATE | morphine sulfate | SOLUTION;ORAL | 202309-001 | Nov 25, 2015 | DISCN | No | No | ⤷ Try it Free | ⤷ Try it Free | |||||
| Lannett Co Inc | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | TABLET;SUBLINGUAL | 205022-001 | Sep 19, 2016 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Lannett Co Inc | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 078281-001 | Jan 20, 2011 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Lannett
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lannett Co Inc | METADATE CD | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021259-003 | May 27, 2003 | 6,344,215 | ⤷ Try it Free |
| Lannett Co Inc | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | 4,517,179 | ⤷ Try it Free |
| Lannett Co Inc | METADATE CD | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021259-002 | Jun 19, 2003 | 6,344,215 | ⤷ Try it Free |
| Lannett Co Inc | METADATE CD | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021259-001 | Apr 3, 2001 | 6,344,215 | ⤷ Try it Free |
| Lannett Co Inc | METADATE CD | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021259-004 | Feb 19, 2006 | 6,344,215 | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for LANNETT drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 10 mg, 20 mg and 30 mg | ➤ Subscribe | 2005-05-13 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | Extended-release Capsules | 40 mg | ➤ Subscribe | 2007-03-15 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
